Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic

By CBJ

Epitopea Expands its Clinical Development and Research Capabilities as it Accelerates to the Clinic

CAMBRIDGE, United Kingdom and MONTREAL, July 10, 2025 (GLOBE NEWSWIRE) — Epitopea, a transatlantic cancer immunotherapeutics company developing accessible, off-the-shelf RNA-based immunotherapies, today announced the formation of its dedicated clinical team and the expansion of its research team. These developments represent a significant milestone in the company鈥檚 ongoing progress in advancing its RNA-based immunotherapies, known […]

Read More…